<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>米内网 | wechat-feeds</title><link>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</link><description>米内网是中国领先的集医药健康产业研究、医院市场研究、零售市场研究、商业渠道研究、互联网在线医药健康信息服务于一体的综合性专业信息服务平台。目前拥有七项数据分析技术获国家专利，每月收集数据3000多万条，有63个专业数据库为医药健康行业服务。</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 21 Apr 2021 17:25:39 +0800</pubDate><image><url>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</url><title>米内网 | wechat-feeds</title><link>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>华东医药蜕变！11款新药、6个新品出击，集采失标品种销量不减，猛攻慢病药、医美</title><link>https://mp.weixin.qq.com/s/MiywQdLBFuY9LjS3oRY3FQ</link><description></description><content:encoded><![CDATA[华东医药蜕变！11款新药、6个新品出击，集采失标品种销量不减，猛攻慢病药、医美]]></content:encoded><pubDate>Wed, 21 Apr 2021 16:29:06 +0800</pubDate></item><item><title>【重磅】齐鲁第7款首家过评注射剂诞生，26个注射剂在路上</title><link>https://mp.weixin.qq.com/s/PlnpEXSZlSbKiHVKYs29fg</link><description></description><content:encoded><![CDATA[【重磅】齐鲁第7款首家过评注射剂诞生，26个注射剂在路上]]></content:encoded><pubDate>Wed, 21 Apr 2021 16:29:06 +0800</pubDate></item><item><title>【瞩目】正大天晴两款1类新药来袭，拿下两个超$10亿新品</title><link>https://mp.weixin.qq.com/s/OhmOLvuHkulncL9-2V_-4A</link><description></description><content:encoded><![CDATA[【瞩目】正大天晴两款1类新药来袭，拿下两个超$10亿新品]]></content:encoded><pubDate>Wed, 21 Apr 2021 16:29:06 +0800</pubDate></item><item><title>【聚焦】$18亿抗精神病药首仿，这家浙江企业将获批</title><link>https://mp.weixin.qq.com/s/OXQzhi-7fDfygXwTkSYx4Q</link><description></description><content:encoded><![CDATA[【聚焦】$18亿抗精神病药首仿，这家浙江企业将获批]]></content:encoded><pubDate>Wed, 21 Apr 2021 16:29:06 +0800</pubDate></item><item><title>【重磅】受疫情影响，2020我国三大终端六大市场药品销售额16437亿，同比负增长8.5%</title><link>https://mp.weixin.qq.com/s/G7V63_jagGbcp6wj2nIDaA</link><description></description><content:encoded><![CDATA[【重磅】受疫情影响，2020我国三大终端六大市场药品销售额16437亿，同比负增长8.5%]]></content:encoded><pubDate>Tue, 20 Apr 2021 17:51:01 +0800</pubDate></item><item><title>【关注】对飚豪森、齐鲁！40亿大品种苑东再下一城</title><link>https://mp.weixin.qq.com/s/AusKasygaqH81zGgrolGeg</link><description></description><content:encoded><![CDATA[【关注】对飚豪森、齐鲁！40亿大品种苑东再下一城]]></content:encoded><pubDate>Tue, 20 Apr 2021 17:51:01 +0800</pubDate></item><item><title>【获批】国产第3家！四川药企入局80亿吸入剂</title><link>https://mp.weixin.qq.com/s/UUyNHJPD_YRB6ZbMypUc_g</link><description></description><content:encoded><![CDATA[【获批】国产第3家！四川药企入局80亿吸入剂]]></content:encoded><pubDate>Tue, 20 Apr 2021 17:51:01 +0800</pubDate></item><item><title>【瞩目】华海大爆发！拿下20亿心血管药、两大品种同日获批</title><link>https://mp.weixin.qq.com/s/VYjm0NhJCGD13r36fnsRgQ</link><description></description><content:encoded><![CDATA[【瞩目】华海大爆发！拿下20亿心血管药、两大品种同日获批]]></content:encoded><pubDate>Tue, 20 Apr 2021 17:51:01 +0800</pubDate></item><item><title>93个独家中药保护品种卖出200亿！步长、片仔癀成功突围，丽珠大爆发</title><link>https://mp.weixin.qq.com/s/6MGJacFhLXjtP3JQdrKlaw</link><description></description><content:encoded><![CDATA[93个独家中药保护品种卖出200亿！步长、片仔癀成功突围，丽珠大爆发]]></content:encoded><pubDate>Mon, 19 Apr 2021 16:27:31 +0800</pubDate></item><item><title>【重磅】恒瑞新药瞄准这个70亿市场，齐鲁、科伦喜提新品</title><link>https://mp.weixin.qq.com/s/rv0GoPD-NYoNm1x6kOkAwQ</link><description></description><content:encoded><![CDATA[【重磅】恒瑞新药瞄准这个70亿市场，齐鲁、科伦喜提新品]]></content:encoded><pubDate>Mon, 19 Apr 2021 16:27:31 +0800</pubDate></item><item><title>【焦点】济川将拿下30亿注射剂，奥赛康份额火箭式上涨</title><link>https://mp.weixin.qq.com/s/i0infxqB-TMbAyhQ_4SpPw</link><description></description><content:encoded><![CDATA[【焦点】济川将拿下30亿注射剂，奥赛康份额火箭式上涨]]></content:encoded><pubDate>Mon, 19 Apr 2021 16:27:31 +0800</pubDate></item><item><title>【火爆】暴涨195%的抗血栓药，这家湖南药企获批了</title><link>https://mp.weixin.qq.com/s/BvU3lC4cREF_wrav1nn0mQ</link><description></description><content:encoded><![CDATA[【火爆】暴涨195%的抗血栓药，这家湖南药企获批了]]></content:encoded><pubDate>Mon, 19 Apr 2021 16:27:31 +0800</pubDate></item><item><title>再鼎医药：我们不追风，我们就是风</title><link>https://mp.weixin.qq.com/s/SsJ1Zntxl8hh9q2JzamD-A</link><description></description><content:encoded><![CDATA[再鼎医药：我们不追风，我们就是风]]></content:encoded><pubDate>Sun, 18 Apr 2021 07:48:43 +0800</pubDate></item><item><title>6连跌市值蒸发超500亿，“医药股一哥”易主！知名药企被中纪委点名，丽珠1.2亿拿下重磅新药</title><link>https://mp.weixin.qq.com/s/fy455537Ilols9ogD7gahw</link><description></description><content:encoded><![CDATA[6连跌市值蒸发超500亿，“医药股一哥”易主！知名药企被中纪委点名，丽珠1.2亿拿下重磅新药]]></content:encoded><pubDate>Sat, 17 Apr 2021 07:57:32 +0800</pubDate></item><item><title>110家药企晒一季度成绩单！18家扭亏，52家翻倍，长春高新、华润三九……净利润超5亿</title><link>https://mp.weixin.qq.com/s/mcaqMHdHeTLeYMFCEwhITg</link><description></description><content:encoded><![CDATA[110家药企晒一季度成绩单！18家扭亏，52家翻倍，长春高新、华润三九……净利润超5亿]]></content:encoded><pubDate>Fri, 16 Apr 2021 16:27:22 +0800</pubDate></item><item><title>【瞩目】科伦冲击辉瑞$53亿大品种！抗感染药首家过评、滴眼液获批</title><link>https://mp.weixin.qq.com/s/P2y4YSMN1NC4-YOPiK2E2A</link><description></description><content:encoded><![CDATA[【瞩目】科伦冲击辉瑞$53亿大品种！抗感染药首家过评、滴眼液获批]]></content:encoded><pubDate>Fri, 16 Apr 2021 16:27:22 +0800</pubDate></item><item><title>【重磅】官宣！网售处方药“开闸”</title><link>https://mp.weixin.qq.com/s/qo4945HBCudv-phxl6I9lQ</link><description></description><content:encoded><![CDATA[【重磅】官宣！网售处方药“开闸”]]></content:encoded><pubDate>Fri, 16 Apr 2021 16:27:22 +0800</pubDate></item><item><title>【获批】石四药拿下超10亿吸入剂！阿斯利康再迎劲敌</title><link>https://mp.weixin.qq.com/s/wmBrDN3TMLk0NNoX_c67UQ</link><description></description><content:encoded><![CDATA[【获批】石四药拿下超10亿吸入剂！阿斯利康再迎劲敌]]></content:encoded><pubDate>Fri, 16 Apr 2021 16:27:22 +0800</pubDate></item><item><title>齐鲁开挂了！拿下两大重磅品种，64个过评品种霸屏，10个拟集采品种蓄势待发</title><link>https://mp.weixin.qq.com/s/6D56VwgIO1OGn_Y-zuCVEg</link><description></description><content:encoded><![CDATA[齐鲁开挂了！拿下两大重磅品种，64个过评品种霸屏，10个拟集采品种蓄势待发]]></content:encoded><pubDate>Thu, 15 Apr 2021 16:25:19 +0800</pubDate></item><item><title>【重磅】第五批集采目录流出！2款超35亿造影剂上榜，恒瑞、扬子江市场遭冲击</title><link>https://mp.weixin.qq.com/s/3IXTS0aFHoxkLf5NwE6Q9g</link><description></description><content:encoded><![CDATA[【重磅】第五批集采目录流出！2款超35亿造影剂上榜，恒瑞、扬子江市场遭冲击]]></content:encoded><pubDate>Thu, 15 Apr 2021 16:25:19 +0800</pubDate></item></channel></rss>